Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hans-Peter Hofmann is active.

Publication


Featured researches published by Hans-Peter Hofmann.


Journal of Medicinal Chemistry | 2003

Benzoylalanine-Derived Ketoamides Carrying Vinylbenzyl Amino Residues: Discovery of Potent Water-Soluble Calpain Inhibitors with Oral Bioavailability

Wilfried Lubisch; Edith Beckenbach; Sabina Bopp; Hans-Peter Hofmann; Arzu Kartal; Claudia Kästel; Tanja Lindner; Marion Metz-Garrecht; Jutta Reeb; Ferdinand Regner; Michael Vierling; Achim Möller


Archive | 1999

Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia

Gerd Steiner; Kurt Schellhaas; Wilfried Lubisch; Uta Holzenkamp; Dorothea Starck; Monika Knopp; Laszlo Szabo; Franz Emling; Francisco Javier Garcia-Ladona; Hans-Peter Hofmann; Liliane Unger


Archive | 1997

Pyrrolyl quinoxalindiones their production and use as AMPA receptor antagonists

Wilfried Lubisch; Berthold Behl; Hans-Peter Hofmann; Laszlo Szabo


Archive | 2000

Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances

Francisco Javier Garcia-Ladona; Laszlo Szabo; Gerd Steiner; Hans-Peter Hofmann


Archive | 2004

Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders

Francisco Javier Garcia-Ladona; Laszlo Szabo; Gerd Steiner; Hans-Peter Hofmann


Archive | 2002

Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia

Gerd Steiner; Kurt Schellhaas; Wilfried Lubisch; Uta Holzenkamp; Dorothea Starck; Laszlo Szabo; Franz Emling; Francisco Javier Garcia-Ladona; Hans-Peter Hofmann; Liliane Unger


Archive | 1999

Verwendung von 2-substituierten 1,2-benzisothiazol-derivaten und von 3-substituierten tetrahydropyridopyrimidinon-derivaten zur prophylaxe und therapie der zerebralen ischämie

Gerd Steiner; Kurt Schellhaas; Wilfried Lubisch; Uta Holzenkamp; Dorothea Starck; Laszlo Szabo; Franz Emling; Francisco Javier Garcia-Ladona; Hans-Peter Hofmann; Liliane Unger


Archive | 1999

Verwendung von Bindungspartnern für 5-HT5-Rezeptoren zur Behandlung neurodegenerativer und neuropsychiatrischer Störungen Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders

Francisco Javi Garcia-Ladona; Laszlo Szabo; Gerd Steiner; Hans-Peter Hofmann


Archive | 1999

Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie Use of compounds of formula I for the prophylaxis and therapy of cerebral ischemia

Gerd Steiner; Kurt Schellhaas; Wilfried Lubisch; Uta Holzenkamp; Dorothea Starck; Laszlo Szabo; Franz Emling; Francisco Javi Garcia-Ladona; Hans-Peter Hofmann; Liliane Unger


Archive | 1997

Pyrrolylchinoxalindione, ihre herstellung und verwendung als ampa-rezeptorantagonisten

Berthold Behl; Hans-Peter Hofmann; Wilfried Lubisch; Laszlo Szabo

Collaboration


Dive into the Hans-Peter Hofmann's collaboration.

Researchain Logo
Decentralizing Knowledge